Probiotic Dietary Supplement Market growing at a CAGR of 7.1% from 2025 to 2030

The global probiotic dietary supplement market size was estimated at USD 9.71 billion in 2024 and is projected to reach USD 14.72 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030. The market is experiencing growth, largely driven by a growing awareness among consumers of the importance of gut health and immunity. 

Key Market Trends & Insights

  • The Asia Pacific probiotic dietary supplement market held the largest revenue share of 44.0% in 2024.
  • By form, the tablets & softgels segment held the largest market share of 39.7% in 2024.
  • By form, the chewable & gummies segment is expected to grow at a CAGR of 8.6% from 2025 to 2030.
  • By application, the gastrointestinal health segment dominated the market with a revenue share of 64.7% in 2024.
  • By end use, the adults segment dominated the probiotic dietary supplement market with a revenue share of 55.1% in 2024.

Key Market Trends & Insights

  • 2024 Market Size: USD 9.71 Billion
  • 2030 Projected Market Size: USD 14.72 Billion
  • CAGR (2025-2030): 7.1%
  • Asia Pacific: Largest market in 2024

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/probiotics-dietary-supplements-market/request/rs1

The incidence of digestive ailments is rapidly increasing, which is anticipated to drive the demand for probiotic products. These products combat harmful bacteria in the gut and are effective in treating conditions such as intestinal inflammation, antibiotic-associated diarrhea, and urogenital infections. Consumer education has also played a pivotal role. Increased media coverage and information dissemination have made people more aware of digestive health issues and their connection to broader health concerns. For instance, nearly three in five U.S. consumers report actively seeking out foods that support their gut microbiome, with fermented foods being among the most popular choices. This heightened awareness has translated into a greater willingness to invest in probiotic supplements.

The focus on gut health has also intensified in recent years, driven by an increasing number of individuals experiencing digestive issues such as irritable bowel syndrome (IBS) and constipation. As a result, gut microflora probiotics have gained popularity as a means of addressing these concerns.

The popularity of probiotic dietary supplements has been steadily increasing due to the convenience of consuming powders and chewable tablets in a variety of appealing flavors such as apple, orange, and raspberry. These supplements contain lactic acid bacteria, specifically Streptococcus thermophilus and Lactobacillus, which help regulate the digestive system and enhance immune responses. Lactobacillus is also effective in treating a range of conditions such as diarrhea, high cholesterol, skin disorders, irritable bowel syndrome, and lung infections.

Consumer Insights

Consumers worldwide increasingly prioritize gut health, immunity, and overall wellness, driving the adoption of probiotic dietary supplements. Convenient and easy-to-consume formats, such as softgels, gummies, chewables, and powders, are preferred, particularly among adults and younger populations. Flavor, palatability, and clean-label ingredients strongly influence purchasing decisions, while scientific validation and regulatory assurances enhance consumer trust. Parents increasingly seek probiotics for infants and children, emphasizing the importance of digestive and immune support from an early age. In addition, the rise of e-commerce and digital health education makes probiotic products more accessible and visible, encouraging frequent and repeated consumption.

Probiotic Dietary Supplement Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 10.46 billion

Revenue forecast in 2030

USD 14.72 billion

Growth rate

CAGR of 7.1% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 – 2023

Forecast period

2025 – 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Form, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Central & South America; Middle East & Africa

Country scope

U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; China; India; Japan; Australia; South Korea; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key company profiled

Vitakem Nutraceutical Inc.; Lesaffre; Herbalife International Inc.; H&H Group; Dr. Joseph Mercola; ADM; Amway; Bayer AG; BioGaia; Nestlé Health Science; NOW Foods; Nature’s Sunshine Products Inc.; Seed Health, Inc.; RenewLife; Goodhealth Products Limited.

Customization scope

Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Similar Posts